Growth Investing: When Paying a Premium Makes Sense
Updated: May 2026 | By Jenna Lofton, StockHitter.com

Jenna’s Bottom Line
Paying a premium for a great business is not a mistake. Paying a premium for a mediocre business dressed up in a growth narrative is. Growth investing done well is about identifying companies whose earnings trajectory will make today’s expensive valuation look cheap in three years. Done poorly, it is just momentum chasing with a better story attached.
Key Takeaways
- Growth investing means buying companies with above-average revenue and earnings growth, often at premium valuations, with the expectation that future earnings power justifies today’s price.
- A high P/E ratio is not automatically expensive. A company growing revenue at 40 percent annually can grow into a high multiple within two to three years. The question is always whether the growth rate justifies the multiple.
- The Rule of 40 is the most reliable single metric for evaluating growth stock health. Revenue growth rate plus profit margin should exceed 40 for a sustainably growing business.
- Valuation compression is the primary risk in growth investing. When interest rates rise or growth decelerates, high-multiple stocks reprice sharply and quickly.
- The AI infrastructure cycle has produced the most compelling growth investing environment in a decade. Companies with durable structural tailwinds and accelerating revenue warrant serious analysis before dismissing their multiples as expensive.
What Growth Investing Actually Is
Here is the simplest version: you are paying more than a stock looks worth today because you believe the business will grow into that price, and then some.
A company growing revenue at 35 percent annually doubles its revenue in roughly two years. If margins hold or expand alongside that growth, earnings compound even faster. A stock that looks expensive at 60 times earnings today can look cheap in three years if earnings have tripled. That is the whole game.
When it works, it works spectacularly. When growth decelerates, the premium multiple collapses at the same time as the earnings disappointment. Both things go wrong simultaneously, which is why growth investing failures tend to be so brutal so fast.
What Actually Justifies a Growth Premium

Not all growth is worth paying for. I have learned this the hard way more than once. The rate of growth matters less than whether that growth is real, durable, and protected.
Three things I look at before accepting any premium valuation:
- Total addressable market size. A company growing at 40 percent in a $500 billion market has years of runway. The same growth rate in a $2 billion market hits a ceiling fast. You need room to grow into.
- Competitive moat. Growth that any well-funded competitor can replicate is not worth a premium. Growth protected by network effects, switching costs, proprietary technology, or regulatory barriers is a completely different asset.
- Unit economics. A business growing revenue by acquiring customers at a loss is not a growth company. It is a company spending investor capital to manufacture a top-line number. Gross margins expanding alongside revenue is the signal I want to see.
The Rule of 40: My First Filter on Any Growth Stock

Before I look at anything else on a growth stock, I run the Rule of 40. It is the fastest way I know to separate businesses that are growing sustainably from ones that are burning cash to fake it.
Take the annual revenue growth rate and add it to the operating profit margin. If the number is above 40, the business passes the first test. A company growing at 30 percent with 15 percent operating margins scores 45. A company growing at 50 percent while losing 5 percent on operations also scores 45. Different paths to the same result, both healthy.
Scores above 60 are where it gets interesting. Palantir Technologies (PLTR) has posted Rule of 40 scores above 60 in recent quarters, driven by accelerating AI platform revenue and expanding margins. That is not a company to dismiss as expensive without doing the work first.
Why Interest Rates Are a Growth Investor’s Biggest External Risk
This is the dynamic that catches the most growth investors off guard, especially those who came of age investing in the post-2010 near-zero rate environment.
Growth stocks are valued on future earnings. When rates rise, those future earnings get discounted at a higher rate, which mathematically reduces what they are worth today. A company whose value sits mostly five to ten years out is far more rate-sensitive than one generating most of its value from current earnings.
The 2022 bear market was a live demonstration. The Fed’s most aggressive rate-hiking cycle in four decades repriced high-multiple growth stocks by 50 to 80 percent in under 12 months. The ones with genuine earnings power recovered. The ones running on narrative mostly did not.
In 2026, with the Fed in an easing cycle, the environment has shifted back in growth investing’s favor. The Federal Reserve’s current policy rate trajectory is worth monitoring as a core input to any growth valuation framework.
How I Evaluate a Growth Stock
Growth analysis is a different toolkit than value analysis. Here are the metrics I actually use:
- Revenue growth rate. Consistent acceleration beats high but decelerating growth every time. A company growing at 25 percent consistently is more valuable than one that grew 60 percent two years ago and is now at 20 percent.
- Gross margin. High and expanding gross margins signal pricing power and scalable economics. Software businesses at 70 to 80 percent gross margins can fund aggressive growth from operations. Low gross margin businesses need external capital and that dilutes you.
- Net Revenue Retention (NRR). For subscription and software businesses, NRR above 120 percent means existing customers are expanding their spend faster than churn reduces it. That is compounding growth from a fixed customer base before new customer acquisition is even counted.
- Rule of 40 score. Already covered. Run it first.
- Price-to-Sales ratio. When earnings are minimal or negative, price-to-sales gives a valuation anchor. A 20x multiple is expensive for a 10 percent grower and potentially reasonable for a 50 percent grower with expanding margins. Context is everything.
Experience Transparency
My most expensive growth investing mistakes came from confusing revenue growth with business quality. In 2021 I held several high-growth companies burning cash at an accelerating rate. When rates rose in 2022, those positions fell 60 to 70 percent. The ones that held up were the companies with real unit economics behind the growth: expanding gross margins, positive free cash flow, Rule of 40 scores above 50. The ones that collapsed had revenue growth as the only thing going for them. Growth is necessary. It is not sufficient. The business behind the growth has to actually work.
Red Flags I Watch For in Every Growth Stock

Spotting these early is where the real edge in growth investing lives. By the time they show up in the headline numbers, you have already lost a significant portion of the position.
- Revenue growth slowing while the multiple expands. When growth is decelerating but the valuation is still expanding on momentum, a painful repricing is being set up. This is one of the most reliable early warning signals I know.
- No path to profitability after five or more years. Some businesses need time. But a company seven years old, generating hundreds of millions in revenue, with no clear profitability timeline has a business model problem, not a growth stage problem.
- Insider selling at peak prices. One executive transaction can be liquidity. A pattern of insider sales across multiple executives at elevated prices is information. Treat it that way.
- Customer concentration above 30 percent. A growth company where one or two customers represent 30 percent or more of revenue has a fragility the growth rate hides. Losing that customer does not just reduce revenue. It destroys the narrative that justified the premium multiple.
Why the AI Infrastructure Cycle Is the Best Growth Investing Environment in Years
I have been investing through multiple cycles and the AI infrastructure build-out is generating the most compelling growth opportunities I have seen since the early years of cloud computing.
The difference this time is that the demand is not speculative. Hyperscalers including Microsoft, Alphabet, Meta, and Amazon have committed hundreds of billions of dollars annually to AI infrastructure capital expenditure. That is contracted, recurring, and accelerating. The growth rates coming out of companies supplying that build-out are not manufactured. They are driven by real customer demand with years of runway left.
Arista Networks (ANET) is the example I keep coming back to. Consistent 20 to 30 percent annual revenue growth. Substantial free cash flow. Expanding operating margins. Rule of 40 scores consistently above 50. The valuation is not cheap by traditional standards. It is justified. Those are different things.
For our full analysis of where the best growth opportunities sit within the AI infrastructure theme, see our coverage of best AI infrastructure stocks to watch in 2026 and our individual breakdown of Broadcom (AVGO), which combines growth and dividend characteristics in a way very few large-cap technology companies pull off.
When to Sell a Growth Stock
This is where most growth investors struggle more than anywhere else. The conviction that kept you in through a 30 percent drawdown can also keep you in through a fundamental deterioration that absolutely warrants an exit. Those are very different situations.
I sell a growth stock when:
- Revenue growth decelerates for two or more consecutive quarters without a clear one-time explanation.
- Gross margins compress in ways management cannot explain convincingly on the earnings call.
- The competitive moat that justified the original thesis is being eroded by a credible competitor.
- The valuation reaches a level where the growth required to justify it exceeds what the total addressable market can realistically support.
- A better opportunity exists elsewhere and capital reallocation makes more sense on a risk-adjusted basis.
For a complete framework on when to exit positions across all investing strategies, see our guide to when to sell a stock.
Wall Street Reality Check
Growth investing attracts the most confident investors and produces the most spectacular failures. The confidence comes from a compelling narrative about a transformative business. The failures come from paying prices that embed five years of perfect execution into today’s stock price, leaving no margin for the inevitable disappointment every business eventually produces. The discipline that separates growth investors who build wealth from those who just experience volatility is simple but rare: they know exactly what has to be true for their thesis to work, they monitor those variables relentlessly, and they sell when those variables stop cooperating. Most growth investors have conviction instead. Conviction is a different and much more dangerous thing.
Bottom Line
Growth investing works when the premium is justified by durable revenue growth, expanding margins, and a competitive moat that protects the trajectory. It fails when the premium is justified by narrative rather than numbers. The Rule of 40, net revenue retention, and gross margin trends will tell you which situation you are actually in. Check them before the market does it for you.
Further Reading
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice. StockHitter.com and Jenna Lofton are not registered investment advisors. All investing involves risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own due diligence and consult a licensed financial professional before making investment decisions. Jenna Lofton holds a position in PLTR. Some links on this page may be affiliate links, meaning StockHitter.com may receive compensation if you subscribe to a service at no additional cost to you. This does not influence our editorial opinions.
